BRIEF-NextCure And Simcere Zaiming Announce Expansion Of Ongoing Phase 1 Trial Of SIM0505 Into The US
Reuters
Oct 16
BRIEF-NextCure And Simcere Zaiming Announce Expansion Of Ongoing Phase 1 Trial Of SIM0505 Into The US
Oct 16 (Reuters) - NextCure Inc NXTC.O:
NEXTCURE AND SIMCERE ZAIMING ANNOUNCE EXPANSION OF ONGOING PHASE 1 TRIAL OF SIM0505 (CDH6 ADC) INTO THE UNITED STATES
NEXTCURE INC - TRIAL TO ACCELERATE PROOF-OF-CONCEPT DATA IN 1H 2026
Source text: ID:nGNX9m3yqn
Further company coverage: NXTC.O
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.